Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
CRT 2019: 1 Year Outcomes From SURTAVI - Dr Steven Yakubov
Author(s): Steven Yakubov Added: 5 years ago
Dr Steven Yakubov (OhioHealth Riverside Methodist Hospital, Columbus, OH, US) discusses 1-year outcomes of TAVR vs SAVR in patients at intermediate surgical risk - a propensity-match analysis from the SURTAVI trial. Filmed on site at CRT 2019 by Radcliffe Cardiology Questions: 1. Why did you conduct this analysis? 2. How was data collected and analysed? 3. What were your findings? 4. How… View more

Intervention
ACC 2019 - Echocardiographic Outcomes From the COAPT Trial
Author(s): Federico M Asch Added: 5 years ago
Dr Federico M Asch (Washington Hospital Center, Washington DC, US) discusses echocardiographic outcomes from the COAPT trial - mitral regurgitation after MitraClip implantation in patients with HF and secondary mitral regurgitation.Filmed on-site at ACC 2019 by Radcliffe Cardiology. Videographer: Josh Birch Educational Lead: Liam O'Neill, Chief Operating Officer View more

Imaging & Diagnostics
Author(s): Giora Weisz Added: 3 years ago
Much has been written, but little is known, about the long-term outcomes after drug-eluting stent (DES). The introduction of DES has extended the use of stents from a passive platform for vessel wall scaffolding to an active biotechnology vehicle for local delivery of antiproliferative pharmacotherapy. Like any other therapy or medical technology, no treatment is perfect and free of potential… View more

Intervention
Outcomes of Complex Percutaneous Cardiac Interventions in Women
Author(s): Mirvat Alasnag , Valeria Paradies , Nicola Ryan , et al Added: 4 months ago

Intervention
Micra CED: 2-Year Outcomes with Leadless Pacing
Author(s): Jonathan Piccini Added: 2 years ago
Dr Jonathan Piccini (Duke University School of Medicine, US) shares the 2-year findings of the Micra CED study. Micra CED study is assessed a Medicare beneficiary population implanted with single-chamber ventricular pacemakers (Medtronic Micra devices). Discussion Points Leadless pacing technology Study design and patient population Key findings Take-home messages for clinicians Next steps … View more

Electrophysiology & Arrhythmia
Optimizing Clinical Outcomes in Acute Decompensated Heart Failure
Author(s): Sabu Thomas , Andrew J Boyle , Gary S Francis Added: 3 years ago
Acute decompensated heart failure (ADHF) is a syndrome defined by worsening fatigue, dyspnea, or edema that results from deteriorating heart function and usually leads to hospital admission or unscheduled medical intervention.1 Among patients over 65 years of age it remains the leading cause of hospital admission (>1 million admissions per year in the US alone), has an exceptionally high rate… View more

Heart Failure
Author(s): Ahmad Younes , Guilherme Ferragut Attizzani , Ankur Kalra Added: 3 years ago
Transcatheter aortic valve replacement (TAVR) is a recent innovation that has transformed the care of patients with symptomatic severe aortic stenosis. It has emerged as an alternative for surgical aortic valve replacement (SAVR) in prohibitive-, high-risk, and more recently, intermediate-risk surgical patients. More than 200,000 TAVRs have been performed in 65 countries around the world.1 As… View more

Vascular Disease and Surgery

Intervention
ECO 23: Impact of Obesity on Heart Failure Outcomes
Author(s): Laura Meems Added: 11 months ago
ECO 23 - We are joined by Dr Laura Meems (University Medical Center Groningen, NL) to discuss the impacts of obesity on the outcomes of heart failure.In this interview, Dr Meems outlines the effects of obesity on the progression and management of heart failure and the available treatment options for patients in 2023.Interview Questions:How does obesity impact the progression and management of… View more

Heart Failure

Prevention & Chronic Conditions
TCT 21: 5Y Outcomes From the BIO-RESORT trial | drug eluting stent
Author(s): Eline H Ploumen Added: 2 years ago
In this short video, Dr Eline H Ploumen (Thoraxcentrum Twente, Medisch Spectrum Twente, Enschede, NL) discusses the 5-yearoutcomesfrom the BIO-RESORT trial. The randomized trial compared the ultrathin-strut and very thin-strut biodegradable polymer DES to thin-strut durable polymer DES. At 1-year follow-up, non-inferiority of the two novel DES was showed. Discussion Points: Rationale… View more

Intervention
ACC.23 Late-Breaker Discussion: The CLEAR-Outcomes Trial
Author(s): Harriette Van Spall , Steven E Nissen Added: 1 year ago
ACC.23/WCC — Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) is joined by principal investigator, Dr Steven Nissen (Cleveland Clinic, Cleveland, OH, US) to have a deep dive into the practice-changing CLEAR-Outcomes trial (NCT02993406).The Phase 3 CLEAR-Outcomes trial was conducted to evaluate the impact of bempedoic acid (ETC-1002) on the occurrence of major cardiovascular… View more

Standards & Guidelines

Prevention & Chronic Conditions